Remove 2014 Remove Clinic Remove Joints
article thumbnail

Brachioradial Pruritus: The Neuropathic Itch Every DC Should Recognize

ChiroUp

1,4,5,9) Cervical spine conditions such as disc herniation, spondylosis, or chronic joint dysfunction hypersensitize these nerves, making them more likely to misfire. (12) Fast Fact Clinically and via the ice pack sign Brachioradial pruritis ICD10: L29.9 - Pruritus, unspecified. American journal of clinical dermatology.

article thumbnail

Heat vs. Cold Therapy: Which is Best for Musculoskeletal Injuries

ChiroUp

Clinical practice guidelines from the Annals of Internal Medicine support heat therapy for reducing pain and improving function across these stages. (26) World journal of clinical cases. Orthopaedic application of cryotherapy: a comprehensive review of the history, basic science, methods, and clinical effectiveness. Kwiecien SY.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The body’s own cannabinoid system for healing

Chiropractic Economics

6 For DCs, this is particularly relevant as many of the conditions treated, such as joint pain, back pain and soft tissue injuries, involve inflammatory processes. As research continues to uncover the complexities of the ECS, its role in health and disease will become increasingly relevant in clinical practice.

article thumbnail

Meralgia Paresthetica: A Commonly Overlooked Cause of Thigh Pain

ChiroUp

The Three Most Essential Tests for Diagnosing Meralgia Paresthetica Recent evidence supports three simple yet powerful clinical tests for meralgia paresthetica diagnosis. 51) Differential Diagnosis Clinical Differentiator L2-L3 radiculopathy Lumbar symptoms, provoked by lumbar testing, possible motor or reflex loss. Pain Pract.

article thumbnail

Dual Mobility Cups in Total Hip Replacement

Orthopedic Principles

Ion Release & Biological Concerns Study: Prospective analysis (2012-2014) on 40 CrCo MDM cases presented at the 2021 World Arthroplasty Congress. Clinical Outcomes in Young Patients Study: 5-year multicenter international study using MDM with highly cross-linked polyethylene. Findings: No adverse local reactions.

article thumbnail

SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales

OrthoSpineNews

PsiFGuard project co-developed with US company Omnia Medical During 2024, SpineGuard finalized the design and industrialization of its new “PsiFGuard” product intended for posterior sacroiliac joint fusion (“PSIF”). It could also be useful for prescribing bone-strengthening treatments post-operatively.

article thumbnail

SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc.

OrthoSpineNews

PsiFGuard is now part of Omnia Medicals comprehensive product offering for ambulatory sacro-iliac joint fusion procedures, a fast growing segment. The latter was cleared by the FDA in September 2024 then officially launched at the end of January 2025 at the NANS (North American Neuromodulation Society) convention in Orlando. OmniaMedical.com.